XNIF:LSE:LSE-Xtrackers Nifty 50 Swap UCITS ETF 1C (GBX)

ETF | Others |

Last Closing

USD 21319

Change

0.00 (0.00)%

Market Cap

USD 0.26B

Volume

4.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-3.00 (-1.33%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-3.14 (-2.25%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.22 (+1.61%)

USD 562.96B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.35 (+1.98%)

USD 562.96B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.35 (+0.56%)

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.57 (+1.96%)

USD 211.57B
0QZ3:LSE Qualcomm Inc.

-1.14 (-0.73%)

USD 202.26B
0R24:LSE Intel Corp.

+0.02 (+0.10%)

USD 196.14B

ETFs Containing XNIF:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.75% 57% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.75% 55% F 58% F
Trailing 12 Months  
Capital Gain 7.44% 56% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.44% 54% F 58% F
Trailing 5 Years  
Capital Gain 65.87% 81% B- 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 65.87% 79% B- 83% B
Average Annual (5 Year Horizon)  
Capital Gain 17.50% 83% B 82% B
Dividend Return 17.50% 82% B 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.15% 51% F 68% D+
Risk Adjusted Return 123.65% 98% N/A 99% N/A
Market Capitalization 0.26B 63% D 36% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike